TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/27/24 17:10 | 9/26/24 | PKTX | Protokinetix, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Smith Clarence Edward | FL | DOT | P,CEO | P.d | 20 | 0.0100 | 0 | 2,000 | 2 | 85,637 | D | ||||||||||||||
6/17/24 15:13 | 6/13/24 | PKTX | Protokinetix, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Smith Clarence Edward | FL | DOT | P,CEO | P.dm | 65 | 0.0100 | 0 | 6,500 | 8 | 83,637 | D | ||||||||||||||
4/15/24 21:45 | 3/20/24 | PKTX | Protokinetix, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Smith Clarence Edward | FL | DOT | P,CEO | P.dm | 35 | 0.0111 | 0 | 3,167 | 4 | 77,137 | D | ||||||||||||||
12/28/23 15:14 | 12/26/23 | PKTX | Protokinetix, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Smith Clarence Edward | FL | DOT | P,CEO | P.d | 110 | 0.0150 | 0 | 7,333 | 11 | 73,970 | D | ||||||||||||||
8/30/23 16:10 | 8/29/23 | PKTX | Protokinetix, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Smith Clarence Edward | FL | DOT | P,CEO | P.d | 30 | 0.0200 | 0 | 1,500 | 2 | 66,637 | D | ||||||||||||||
6/15/23 15:55 | 6/15/23 | PKTX | Protokinetix, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Smith Clarence Edward | FL | DOT | P,CEO | P.d | 40 | 0.0200 | 0 | 2,000 | 3 | 65,137 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |